FN2 Earnings Intelligence

TG Therapeutics, Inc. cash flow

TG Therapeutics, Inc. (TGTX) Cash Flow (annual) derived from persisted SEC financial facts.

Cash Flow

USD in millions, except per-share values and percentages.

Metric 12/31/202112/31/202212/31/202312/31/202412/31/2025
Operating Cash Flow -$295.6-$176.2-$31.4-$40.5-$24.8
Capital Expenditure $0.4$0$0$0$0.2
Free Cash Flow -$296-$176.2-$31.4-$40.6-$25

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.